Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bryant

Showing results (281-290 of 307) with videos related to

Pageof 31
Sort By:
The Journal of Biological Chemistry|March 14, 1997
Activation of multiple interleukin-1beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosisL M Martins, T Kottke, P W Mesner, et al.
Practical Radiation Oncology|April 26, 2023
Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality CollaborativeSteven G Allen, Aleksandar F Dragovic, Huiying Maggie Yin, et al.
JCO Oncology Practice|June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted AnalysisGarth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
Neurology|July 23, 2003
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathologyM A Pappolla, T K Bryant-Thomas, D Herbert, et al.
HIV Medicine|May 18, 2016
The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapyE J Edelman, K S Gordon, J P Tate, et al.
JAMA Internal Medicine|May 7, 2019
Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate CancerReith R Sarkar, J Kellog Parsons, Alex K Bryant, et al.
Cancer Medicine|June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advancesAlex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
Cancer Medicine|November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare SystemSean R Miller, Matthew Schipper, Lars G Fritsche, et al.
Veterinary Parasitology, Regional Studies and Reports|April 25, 2019
Postmortem examination (2016-2017) of weanling and older horses for the presence of select species of endoparasites: Gasterophilus spp., Anoplocephala spp. and Strongylus spp. in specific anatomical sitesE T Lyons, D C Bolin, U K Bryant, et al.
The Lancet. Oncology|May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health systemAlex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
Pageof 31

Showing results (281-290 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Biological Chemistry|March 14, 1997
Activation of multiple interleukin-1beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosisL M Martins, T Kottke, P W Mesner, et al.
Practical Radiation Oncology|April 26, 2023
Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality CollaborativeSteven G Allen, Aleksandar F Dragovic, Huiying Maggie Yin, et al.
JCO Oncology Practice|June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted AnalysisGarth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
Neurology|July 23, 2003
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathologyM A Pappolla, T K Bryant-Thomas, D Herbert, et al.
HIV Medicine|May 18, 2016
The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapyE J Edelman, K S Gordon, J P Tate, et al.
JAMA Internal Medicine|May 7, 2019
Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate CancerReith R Sarkar, J Kellog Parsons, Alex K Bryant, et al.
Cancer Medicine|June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advancesAlex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
Cancer Medicine|November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare SystemSean R Miller, Matthew Schipper, Lars G Fritsche, et al.
Veterinary Parasitology, Regional Studies and Reports|April 25, 2019
Postmortem examination (2016-2017) of weanling and older horses for the presence of select species of endoparasites: Gasterophilus spp., Anoplocephala spp. and Strongylus spp. in specific anatomical sitesE T Lyons, D C Bolin, U K Bryant, et al.
The Lancet. Oncology|May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health systemAlex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
Pageof 31